The Timeline of Opioid Withdrawal: How Long Symptoms Last

Table of Contents

Opioid withdrawal is a well-recognized medical process that happens when chronic opioid use is stopped or significantly reduced. Understanding the typical timeline can help individuals prepare for detox, manage symptoms safely, and reduce the risk of relapse. 

While experiences vary depending on the type of opioid used, dosage, length of use, and overall health, knowing what to expect makes the process more manageable. This article explains the common stages of opioid withdrawal, how long symptoms usually last, and what factors can influence recovery.

What Is Opioid Withdrawal?

Opioid withdrawal occurs when the body reacts to the sudden absence or reduction of opioids after prolonged use. Opioids work by binding to mu-opioid receptors in the brain and nervous system, reducing pain signals and creating feelings of relaxation or euphoria. The brain eventually adapts to their presence and begins to rely on them to function normally.

When opioid use stops or is significantly reduced, the nervous system becomes overstimulated as it tries to rebalance itself. This overcorrection causes the uncomfortable physical and emotional effects known as withdrawal.

Short-Acting vs. Long-Acting Opioids

Short-acting opioids, such as heroin, codeine, or immediate-release oxycodone, are quickly metabolized by the body. Because they leave the system rapidly, withdrawal tends to begin within 6 to 12 hours after the last dose. Although the signs appear sooner, they typically last for a shorter period, often resolving within a week to 10 days. However, the early stages can be intense, marked by anxiety, muscle aches, and flu-like discomfort.

In contrast, long-acting opioids, including methadone, extended-release oxycodone, and morphine ER, are processed more slowly. Withdrawal typically begins 24 to 72 hours after the last dose, but can last for 10 to 20 days. Symptoms may develop more gradually and are often less severe, but can persist for an extended period.

Partial agonists like buprenorphine bind tightly to opioid receptors but only partially activate them. This produces a delayed cessation onset, typically 36 to 72 hours or more, and symptoms are generally milder compared to full opioid agonists.

Typical Withdrawal Timeline

Onset

  • Short-acting: 6–12 hours after the last dose
  • Long-acting: 24–72 hours after the last dose
  • Buprenorphine: 36–72 hours or longer

Peak Intensity

  • Short-acting: 48–72 hours after last dose
  • Long-acting: day 3–8
  • Buprenorphine: days 3–5, typically milder in intensity

Duration

  • Short-acting: symptoms improve within 5–10 days
  • Long-acting: may last 10–20 days
  • Buprenorphine: symptoms are generally mild but can linger longer

Common Symptoms

Early symptoms often include autonomic rebound and restlessness, characterized by anxiety, irritability, yawning, a runny nose, watery eyes, sweating, chills, goose bumps, muscle aches, back pain, insomnia, and general restlessness. 

Later symptoms tend to be gastrointestinal and systemic, such as abdominal cramping, nausea, vomiting, diarrhea, dilated pupils, light sensitivity, elevated heart rate and blood pressure, fatigue, and disrupted sleep.

Even after the acute cessation phase ends, many people experience lingering effects such as sleep disturbances, low mood, anxiety, or cravings. This protracted adjustment period, known as Post-Acute Withdrawal Syndrome (PAWS), can last for weeks or months, underscoring the importance of ongoing support and medical supervision.

opioid tapering process

Factors That Influence Duration

Several factors affect how long the symptoms last. The type and formulation of the opioid play a significant role, with long-acting or high-potency narcotics like fentanyl patches extending timelines. Higher doses and more frequent use also worsen and prolong symptoms, as does a longer duration of use. Individual biology, including age, liver and kidney function, metabolic rate, and genetic differences in opioid metabolism, can influence the experience. 

Co-occurring conditions such as anxiety, depression, chronic pain, or other substance use may complicate the halting process. Whether a taper or abrupt cessation is used affects onset, intensity, and duration, with medically supervised tapers generally producing a smoother and safer process.

Managing Opioid Withdrawal Safely

Medical supervision is strongly recommended, as unmanaged withdrawal increases the risk of relapse and overdose due to rapidly lost tolerance. Many individuals benefit from a Suboxone treatment program, as this medication contains buprenorphine and naloxone, thereby helping ease withdrawal symptoms and cravings by partially activating opioid receptors without producing the same euphoric effects as full opioids. 

Methadone is useful for severe dependence, particularly from long-acting painkillers, and is provided through licensed programs. Alpha-2 agonists such as lofexidine or clonidine can ease autonomic symptoms like sweating, elevated heart rate, and anxiety when MAT is not used. Symptomatic supports such as antiemetics for nausea, antidiarrheals for diarrhea, NSAIDs or acetaminophen for aches, and good sleep hygiene can also help manage discomfort.

Supportive care is equally important. Staying hydrated, maintaining electrolyte balance, and eating balanced, frequent meals stabilize energy and blood sugar levels. Temperature regulation strategies, like layered clothing or cool showers, can help manage chills and sweats, and low-intensity activity paired with organized routines supports mood and sleep. 

Final Thoughts from Raise the Bottom

Opioid withdrawal follows a predictable pattern, though its intensity and duration vary from person to person. Factors such as the type of opioid used, overall health, and the presence of professional support can all influence the process. What remains consistent is that medically guided care and evidence-based treatment greatly reduce the discomfort and risks associated with withdrawal, helping individuals move safely toward recovery.

At Raise the Bottom, we offer a Suboxone treatment program designed to ease withdrawal, reduce cravings, and support long-term recovery. Our compassionate team provides personalized care in a safe environment, helping you regain stability, rebuild confidence, and take the next step toward a life free from opioid dependence.

Facebook
Twitter
LinkedIn
WhatsApp

Nina Abul-Husn, MD, MSPH

Nina Abul-Husn

Medical Director For Raise The Bottom Addiction Treatment

Dr. Nina Abul-Husn is a dual Board-Certified Family Medicine Physician and Addiction Medicine Specialist. She has an extensive background in the life sciences, having graduated from Indiana University with a degree in biochemistry and microbiology, as well as a background in public health and tropical medicine, having graduated with a Master’s degree from Tulane University School of Public Health and Tropical Medicine. She completed her medical training and has been practicing in the Treasure Valley since 2012.

Ready to Take the Next Step?

Recovery is possible, and you don’t have to go through it alone. Contact Raise the Bottom today to begin personalized addiction treatment built around your goals.